(Q58817152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

L J Lesko

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M Rowland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C C Peck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D Breimer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H J de Jong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Grahnen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J J Kuhlmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

B Stewart

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmaceutical Sciences

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

iv-xiv

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900092-0

7 January 2021

Pharmacologically guided phase I clinical trials based upon preclinical drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900092-0

7 January 2021

The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900092-0

7 January 2021

Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B).

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900092-0

7 January 2021

Simulation of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900092-0

7 January 2021

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900092-0

7 January 2021

An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience within Hoffmann La Roche

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900092-0

7 January 2021

Learning versus confirming in clinical drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900092-0

7 January 2021

Pharmacokinetic/pharmacodynamic modeling in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2800%2900092-0

7 January 2021

10.1016/S0928-0987(00)00092-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11023342%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference